What are the most important lessons to be learnt f...
Phacilitate's Investment for Advanced Therapies in partnership with Biotech...
Read MoreThe headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember:
Get our executive insight into your inbox
Phacilitate's Investment for Advanced Therapies in partnership with Biotech...
Read MoreWith the date for Brexit rapidly approaching, the realisation is hitting ho...
Read MoreAs Phacilitate prepares to launch their Investment in Advanced Therapies Su...
Read MoreThere are several self-perpetuating myths and attitudes in the Biotech sect...
Read MoreHighlights Capital Cell’s crowdfunding campaign - Bionure - overfunds with ...
Read MoreTom Weaver CEO Congenica Using data analytics and applying their software t...
Read MoreInvestment for Advanced Therapies will be the C-Level meeting place for hea...
Read MoreBy Kristian Wiggert Partner Covington & Burling LLP, London The recent stro...
Read MoreBiotechs and the City Spring is the latest quarterly networking event for s...
Read MoreBiotech and Money are pleased to announce the release of the latest Drugs &...
Read MoreThis is the third in a series of four articles which aim to provide tips fo...
Read MoreHere are some lessons we learned during a recent interview with CFO Alan Ol...
Read MoreThe Drugs & Dealers Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
Connecting Europe's Life Science corporates with capital.
Biotech and Money is the influential community of senior life science decision makers
© 2016 All Rights Reserved By Biotech and Money
Add Your Response